CRITICAL CARE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-10-06 wenjian1998

投稿命中率:25.0 | 版面费用:2700.0
偏重的研究方向：危重病临床
经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！

985 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2024-09-30 ms8000001161552998 来自黑龙江省

偏重的研究方向：重症
经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞

1 0

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-05-11 12308a52m60(暂无昵称)

收宝藏女孩 2019-08-31 发表::
前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表:
前辈，这个杂志貌似不收个案是吗，我想确定一下

宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下

1065 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-10-09 1109255883_45635588

审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0
偏重的研究方向：重症;心血管;临床研究
经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。
所以来补充一下，希望对其他人有所帮助。
杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。
之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。
大修一个月，修回后，半个月有了二审的结果，还是很快的！
之后就是小修，返回去后一周接收（应该是没有再送外审了）
唯一的缺点就是版面费略贵...得找爸妈帮忙交...

1250 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-27 MS54455111222

如何计算相关性？

842 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-27 小动量

什么是协同作用？什么是相加作用？两者有什么区别？

1008 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-08-20 ms4000000395805596

版面费用:3490.0
经验分享：太贵

696 0

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-06-27 ms7000001790578031

#新冠肺炎#看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢

1064 0

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-01-09 king-james

内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表:
审稿后又Reviewers Assigned

180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned

1249 0

[GetPortalCommentsPageByObjectIdResponse(id=890436, encodeId=6f1e89043631, content=投稿命中率:25.0 | 版面费用:2700.0 偏重的研究方向：危重病临床 经验分享：第四次投crit care，脓毒症单中心观察性研究，7月6号投稿，8月19号返回大修，三个审稿人，1个意见完全负面的，另外2个意见比较友好，按要求补了实验和数据，赶在deadline前2天投了修改稿，刚好在国庆中秋双节当天接收，非常开心。感觉还是注重新颖性，不在于多么复杂的统计学套路，根据稿件状态推测，初审的时候估计一个审稿人意见负面，编辑还是不想放弃，增加了一个审稿人。最终的结果非常满意，感谢Vincent教授的认可！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=985, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11972018172, createdName=wenjian1998, createdTime=Tue Oct 06 22:42:08 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2228568, encodeId=8841222856886, content=偏重的研究方向：重症 经验分享：写了一篇给重症医师的猴痘科普短文，9月5号提交，21号一审结束，3个审稿人都持赞赏态度，返修后9月30号接收。期刊的速度极快，审稿人也非常专业。点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987a5721343, createdName=ms8000001161552998, createdTime=Mon Sep 30 16:37:16 CST 2024, time=2024-09-30, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=590636, encodeId=964d590636e6, content=收宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下宝藏女孩 2019-08-31 00:00:00 发表: 前辈，这个杂志貌似不收个案是吗，我想确定一下, beContent=宝藏女孩 2019-08-31 发表:: 前辈，这个杂志貌似不收个案是吗，我想确定一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1065, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373f2377913, createdName=12308a52m60(暂无昵称), createdTime=Mon May 11 00:00:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890775, encodeId=09f6890e75c4, content=审稿速度:3.0 | 投稿命中率:75.0 | 版面费用:3290.0 偏重的研究方向：重症;心血管;临床研究 经验分享：因为我投稿的时候也在到处查期刊的审稿速度，没有看见太多相关信息。 所以来补充一下，希望对其他人有所帮助。 杂志主要还是收临床相关的文章，一审大概两个月有结果，前期在new submission卡了比较长的时间，可能稿件量比较大，处理得慢一些，可以耐心等一等。 之后拿到大修结果，必须夸一夸期刊找的审稿人，都相当专业，提的修改意见都特别好，也不会刁难人，按照审稿人意见好好改，哪怕不中，转投其它期刊文章档次也能上一个台阶。 大修一个月，修回后，半个月有了二审的结果，还是很快的！ 之后就是小修，返回去后一周接收（应该是没有再送外审了） 唯一的缺点就是版面费略贵...得找爸妈帮忙交... , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1250, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3382288550, createdName=1109255883_45635588, createdTime=Fri Oct 09 12:28:02 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087131, encodeId=6ef3108e131e3, content=如何计算相关性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=842, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087132, encodeId=0fe3108e13256, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1008, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009631, encodeId=e8ad10096310d, content=版面费用:3490.0 经验分享：太贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=696, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10315412511, createdName=ms4000000395805596, createdTime=Fri Aug 20 09:00:15 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800058, encodeId=2d12800058f8, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>看了两天投稿指南，觉得fig为啥会要求4－6个呢？这是真的吗？我看近期发表的都是一两个，两三个fig啊？哪位大神帮忙回答一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1064, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33e25395500, createdName=ms7000001790578031, createdTime=Sat Jun 27 23:54:35 CST 2020, time=2020-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582967, encodeId=679858296e49, content=内部审稿？180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, beContent=180e24m5503(暂无昵称) 2019-08-08 23:42:00 发表: 审稿后又Reviewers Assigned, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1249, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c1c1659623, createdName=king-james, createdTime=Thu Jan 09 00:00:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578809, encodeId=41d95e880993, content=不知道，等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1042, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

不知道，等待中

1042 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务